Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Cervical Cancer

1 Open Trial

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCBRE1681

    01/27/2017

    A Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumour Activity of Ascending Doses of AZD5363 under Adaptable Dosing Schedules in Patients with Advanced Solid Malignancies


    Print this page for your doctor